About The Third Hospital of Changsha
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2
The Third Xiangya Hospital of Central South University
2
Bayer
1
BioRegen Biomedical (CHangzhou) Co., Ltd
1
Cui Yimin
1
Hangzhou Sciwind Biosciences Co., Ltd.
1
Jiangsu HengRui Medicine Co., Ltd.
1
PegBio Co., Ltd.
1
Peking University Third Hospital
1
Second Xiangya Hospital of Central South University
1
Clinical Trials at The Third Hospital of Changsha
During the past decade, The Third Hospital of Changsha conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
2012-10-01
2022-06-01
Completed
18,260
The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions
2011-06-01
2013-04-01
Completed
216
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants
2017-06-06
2021-12-01
Unknown status
1,200
Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome
2018-01-15
2021-11-30
Completed
2,055
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Third Hospital of Changsha" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials
sponsored, "The Third Xiangya Hospital of Central South University" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "BioRegen Biomedical (CHangzhou) Co., Ltd"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Third Hospital of Changsha"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Ankang City Central Hospital" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Beihua University" with 1 trials as a collaborator and "Beijing Chuiyangliu Hospital(Beijing Minimally Invasive Hospital)" with 1 trials as a collaborator. Other collaborators include 53 different institutions and companies that were
collaborators in the rest 63 trials.
Clinical Trials Conditions at The Third Hospital of Changsha
According to Clinical.Site data, the most researched conditions in "The Third Hospital of Changsha" are
"Acute Coronary Syndrome" (2 trials), "Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Type 2 Diabetes Mellitus (T2DM)" (2 trials) and "Accurate Medication" (1 trials). Many other conditions were trialed in "The Third Hospital of Changsha" in a lesser frequency.
Clinical Trials Intervention Types at The Third Hospital of Changsha
Most popular intervention types in "The Third Hospital of Changsha" are "Drug" (11 trials), "Device" (2 trials), "Behavioral" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Acarbose" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Third Hospital of Changsha
The vast majority of trials in "The Third Hospital of Changsha" are
13 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at The Third Hospital of Changsha
Currently, there are NaN active trials in "The Third Hospital of Changsha".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in The Third Hospital of Changsha,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Third Hospital of Changsha, 5 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".